Newsletter Archive

  1. 05.22.17 -- Amgen Vs. Sandoz: Who Will Win Over The Supreme Court?
    5/22/2017
    05/22/17 BioProcess Online Newsletter
  2. 05.17.17 -- Trump’s Deregulatory Agenda: What It Means For Biopharma & Medtech
    5/17/2017
    05/17/17 BioProcess Online Newsletter
  3. 05.16.17 -- Oral Delivery Of Challenging Molecules
    5/16/2017
    05/16/17 BioProcess Online Newsletter
  4. 05.15.17 -- Are "Do-Overs" Practical In Biopharmaceutical Manufacturing?
    5/15/2017
    05/15/17 BioProcess Online Newsletter
  5. 05.10.17 -- How To Optimize Your Stability Program At Each Phase Of Drug Development
    5/10/2017
    05/10/17 BioProcess Online Newsletter
  6. 05.08.17 -- 4 Key Considerations When Engaging A New GMP Contract Service Provider
    5/8/2017
    05/08/17 BioProcess Online Newsletter
  7. 05.03.17 -- Are You (Inadvertently) Teaching Your Personnel To NOT Think?
    5/3/2017
    05/03/17 BioProcess Online Newsletter
  8. 04.26.17 -- Measuring The Impact Of Recent Regulatory Guidances On Quality Systems
    4/26/2017
    04/26/17 BioProcess Online Newsletter
  9. 04.24.17 -- Interacting With The FDA — Best Practices For Drug Development Success
    4/24/2017
    04/24/17 BioProcess Online Newsletter
  10. 04.19.17 -- Automating Compliance Operations Using Motor, Sensor, & Decider Bots
    4/19/2017
    04/19/17 BioProcess Online Newsletter